Polycystic ovary syndrome: etiology, current management, and future therapeutics

S Singh, N Pal, S Shubham, DK Sarma… - Journal of Clinical …, 2023 - mdpi.com
Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder, typically
characterized by anovulation, infertility, obesity, insulin resistance, and polycystic ovaries …

[HTML][HTML] Endometriosis: part I. basic concept

PH Wang, ST Yang, WH Chang, CH Liu, FK Lee… - Taiwanese Journal of …, 2022 - Elsevier
Endometriosis, manifested by pain and infertility, is a chronic inflammatory disease,
associated with a large disability of daily living, causing a socio-economic diastrophic …

[HTML][HTML] Endometrial cancer: part I. Basic concept

PH Wang, ST Yang, CH Liu, WH Chang, FK Lee… - Taiwanese Journal of …, 2022 - Elsevier
Endometrial cancer (EC) has become one of rapidly increasing women's cancers,
contributing to the most common cancer of the female genital tract in high-and middle …

[HTML][HTML] The Pathophysiological Mechanism and Clinical Treatment of Polycystic Ovary Syndrome: A Molecular and Cellular Review of the Literature

KJ Chang, JH Chen, KH Chen - International journal of molecular …, 2024 - mdpi.com
Polycystic ovary syndrome (PCOS) is a prevalent metabolic disorder among women of
reproductive age, characterized by hyperandrogenism, ovulatory dysfunction, and polycystic …

Cannabinoids and PPAR ligands: the future in treatment of polycystic ovary syndrome women with obesity and reduced fertility

P Przybycień, D Gąsior-Perczak, W Placha - Cells, 2022 - mdpi.com
Cannabinoids (CBs) are used to treat chronic pain, chemotherapy-induced nausea and
vomiting, and multiple sclerosis spasticity. Recently, the medicinal use of CBs has attracted …

To do one and to get more: Part I. Diabetes and bone

WL Lee, PH Wang, ST Yang, CH Liu… - Journal of the …, 2022 - journals.lww.com
Type 2 diabetes mellitus (T2DM), is a chronic metabolic disease, characterized by the
presence of hyperglycemia and insulin resistance. The key treatment strategies for T2DM …

Polycystic ovary syndrome: Causes, symptoms, pathophysiology, and remedies

A Chaudhuri - Obesity Medicine, 2023 - Elsevier
Polycystic ovary syndrome (PCOS), an endocrine and metabolic disorder during the
reproductive age of women, is characterized by high androgen levels, irregular menses, and …

To do one and to get more: Part II. Diabetes and metabolic dysfunction-associated fatty liver diseases

WL Lee, PH Wang, ST Yang, CH Liu… - Journal of the …, 2022 - journals.lww.com
Type 2 diabetes mellitus (DM) is characterized by inability of faulty pancreatic β-cells to
secret a normal amount of insulin to maintain normal body consumption, and/or peripheral …

Polycystic ovarian syndrome: Current scenario and future insights

S Kulkarni, K Gupta, P Ratre, PK Mishra, Y Singh… - Drug Discovery …, 2023 - Elsevier
Polycystic ovarian syndrome (PCOS) prevails in approximately 33% of females of
reproductive age globally. Although the root cause of the disease is unknown, attempts are …

[HTML][HTML] Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome

K Hussein, M Karami - Saudi pharmaceutical journal, 2023 - Elsevier
Background Polycystic ovary syndrome (PCOS) is an endocrine disorder experienced by
women of reproductive age and is marked by insulin resistance (IR) and menstrual cycle …